Novel methodologies for the preparation of a-substituted serines are described. A newly designed bislactim ether, ethyl (5
S) - or (5
R) -3, 6-diethoxy-2, 5-dihydro-5-isopropyl-2-pyrazinecarboxylate, was treated with base or Lewis acid-tertiary amine to generate an enolate or enaminate (imine anion, metalloenamine). Alkylation or aldol-type reaction with the resultant enolate or enaminate proceeded in a highly diastereoselective manner to give the corresponding products. Reduction of these diastereomers followed by hydrolysis afforded the desirable α-substituted serines. The highly enantioselective aldol-type reaction of an achiral bislactim ether, ethyl 3, 6-diethoxy-2, 5-dihydro-2-pyrazinecarboxylate, was also achieved by employing Sn (OSO
2CF
3)
2-triethylamine in the presence of a catalytic amount of (-) -sparteine. Interestingly, the stereoselective outcome of the Sn (II) -mediated reaction differed from that of the Mg (II) -mediated one in the aldol-type reaction of the bislactim ethers with aliphatic aldehydes.
On the other hand, chemoenzymatic synthesis of enantiomerically pure α-substituted serines must also be a convenient and useful procedure. Porcine liver esterase (PLE) or rabbit liver esterase (RLE) catalyzed hydrolysis of the pro-S ester group of diethyl α-alkyl-α- (benzyloxycarbonylamino) malonates to afford (
R) -ethyl α-alkyl-α- (benzyloxycarbonylamino) malonates each in excellent enantiomeric excess. Enantiodivergent reductions of these acid esters readily furnished both the corresponding enantiomeric α-substituted serines.
Finally, the application of these methodologies mentioned above to a total synthesis of ISP-I (a potent immunosuppressant) and (+) -conagenin (a low molecular weight immunomodulator) is described.
View full abstract